Prevest Denpro [PREVEST] vs Centennial Surgical [CSURGSU] Detailed Stock Comparison
Prevest Denpro
BSE
Loading...
Centennial Surgical
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Prevest Denpro wins in 11 metrics, Centennial Surgical wins in 7 metrics, with 0 ties. Prevest Denpro appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Prevest Denpro | Centennial Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.86 | 2,482.50 | Prevest Denpro |
| Price-to-Book Ratio | 6.35 | 1.82 | Centennial Surgical |
| Debt-to-Equity Ratio | 0.00 | 108.97 | Prevest Denpro |
| EV/EBITDA | 26.13 | 16.07 | Centennial Surgical |
| Profit Margin (TTM) | 28.81% | -2.74% | Prevest Denpro |
| Operating Margin (TTM) | 32.92% | 6.05% | Prevest Denpro |
| EBITDA Margin (TTM) | 32.92% | 6.05% | Prevest Denpro |
| Return on Equity | 18.70% | -4.65% | Prevest Denpro |
| Return on Assets (TTM) | 12.17% | 1.53% | Prevest Denpro |
| Free Cash Flow (TTM) | $128.49M | $56.05M | Prevest Denpro |
| 1-Year Return | 3.30% | 40.78% | Centennial Surgical |
| Price-to-Sales Ratio (TTM) | 10.63 | 1.04 | Centennial Surgical |
| Enterprise Value | $5.77B | $891.12M | Prevest Denpro |
| EV/Revenue Ratio | 9.16 | 1.67 | Centennial Surgical |
| Gross Profit Margin (TTM) | 86.70% | 73.40% | Prevest Denpro |
| Revenue per Share (TTM) | $53 | $147 | Centennial Surgical |
| Earnings per Share (Diluted) | $15.14 | $-4.01 | Prevest Denpro |
| Beta (Stock Volatility) | 0.51 | 0.49 | Centennial Surgical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Prevest Denpro vs Centennial Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Prevest Denpro | -0.54% | 1.45% | 3.87% | 15.53% | 14.34% | -7.00% |
| Centennial Surgical | 1.29% | 5.12% | -1.90% | 24.05% | 14.39% | 13.97% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Prevest Denpro | 3.30% | 65.82% | 110.57% | 110.57% | 110.57% | 110.57% |
| Centennial Surgical | 40.78% | 192.45% | 272.15% | 214.08% | 7,351.92% | 14,661.90% |
Performance & Financial Health Analysis: Prevest Denpro vs Centennial Surgical
| Metric | PREVEST | CSURGSU |
|---|---|---|
| Market Information | ||
| Market Cap | ₹6.70B | ₹558.19M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 5,120 | 134 |
| 90 Day Avg. Volume | 12,460 | 180 |
| Last Close | ₹555.00 | ₹157.00 |
| 52 Week Range | ₹393.60 - ₹686.00 | ₹82.15 - ₹169.50 |
| % from 52W High | -19.10% | -7.37% |
| All-Time High | ₹686.00 (Jan 13, 2025) | ₹169.50 (Dec 16, 2024) |
| % from All-Time High | -19.10% | -7.37% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.10% |
| Quarterly Earnings Growth | 0.08% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | -0.03% |
| Operating Margin (TTM) | 0.33% | 0.06% |
| Return on Equity (TTM) | 0.19% | -0.05% |
| Debt to Equity (MRQ) | 0.00 | 108.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹87.89 | ₹84.30 |
| Cash per Share (MRQ) | ₹54.61 | ₹0.60 |
| Operating Cash Flow (TTM) | ₹148.17M | ₹170.74M |
| Levered Free Cash Flow (TTM) | ₹106.82M | ₹-42,696,752 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Prevest Denpro vs Centennial Surgical
| Metric | PREVEST | CSURGSU |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.86 | 2,482.50 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 10.63 | 1.04 |
| Price to Book (MRQ) | 6.35 | 1.82 |
| Market Capitalization | ||
| Market Capitalization | ₹6.70B | ₹558.19M |
| Enterprise Value | ₹5.77B | ₹891.12M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.16 | 1.67 |
| Enterprise to EBITDA | 26.13 | 16.07 |
| Risk & Other Metrics | ||
| Beta | 0.51 | 0.49 |
| Book Value per Share (MRQ) | ₹87.89 | ₹84.30 |
Financial Statements Comparison: Prevest Denpro vs Centennial Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PREVEST | CSURGSU |
|---|---|---|
| Revenue/Sales | ₹184.55M | ₹133.08M |
| Cost of Goods Sold | ₹24.54M | ₹35.40M |
| Gross Profit | ₹160.01M | ₹97.68M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹60.76M | ₹8.05M |
| EBITDA | ₹76.23M | ₹21.17M |
| Pre-Tax Income | ₹71.51M | ₹-13.38M |
| Income Tax | ₹20.16M | ₹-1.54M |
| Net Income (Profit) | ₹51.41M | ₹-11.84M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PREVEST | CSURGSU |
|---|---|---|
| Cash & Equivalents | ₹608.98M | ₹2.20M |
| Total Current Assets | ₹857.16M | ₹629.64M |
| Total Current Liabilities | ₹59.62M | ₹318.30M |
| Long-Term Debt | ₹0 | N/A |
| Total Shareholders Equity | ₹1.06B | ₹307.55M |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹268.13M | ₹199.83M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PREVEST | CSURGSU |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PREVEST | CSURGSU |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 5,120 | 134 |
| Average Daily Volume (90 Day) | 12,460 | 180 |
| Shares Outstanding | 12.00M | 3.65M |
| Float Shares | 2.61M | 615,942 |
| % Held by Insiders | 0.78% | 0.81% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Prevest Denpro vs Centennial Surgical
| Metric | PREVEST | CSURGSU |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |